Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019

Area of Science:

• Medicine
• Cardiology
• Public Health

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, rapidly spread globally, leading to widespread societal measures like lockdowns.
• Healthcare systems and research activities faced unprecedented challenges in maintaining operations during the pandemic.
• Clinical trials, essential for medical advancement, require close interaction between patients, clinicians, and researchers, posing logistical hurdles during isolation periods.

Purpose of the Study:

• To summarize the acute effects and consequences of the COVID-19 pandemic on ongoing cardiovascular clinical trials.
• To highlight the challenges faced by cardiovascular research during the pandemic.
• To inform strategies for mitigating the impact of future pandemics on clinical research.

Main Methods:

• Literature review and synthesis of available data on the impact of COVID-19 on clinical trials.
• Analysis of challenges related to patient recruitment, data collection, and trial management.
• Examination of institutional and governmental responses to support ongoing research.

Main Results:

• The pandemic led to significant disruptions in patient recruitment and trial conduct for cardiovascular studies.
• Isolation measures and resource reallocation to COVID-19 response impeded the progress of non-COVID-19 related trials.
• Despite challenges, healthcare practitioners and institutions adapted to maintain essential research activities.

Conclusions:

• The COVID-19 pandemic presented substantial obstacles to the timely completion of cardiovascular clinical trials.
• Adaptability and innovative approaches are crucial for sustaining clinical research during public health crises.
• Understanding these impacts is vital for ensuring the continuity of medical research and therapeutic development.